Clinical Trial Update: Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT

View source ↗

Summary

This clinical trial investigates uptake of Cu-ATSM (61Cu) in carotid atherosclerotic plaque using PET-CT, but the study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Atherosclerosis

Drugs mentioned

• Cu-ATSM (61Cu) (Cu-ATSM)

Snippet

Sponsor: King's College London | Conditions: Carotid Atherosclerosis | Status: SUSPENDED